ארזרה 1000 מ"ג
glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab
ארזרה 100 מ"ג
glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab
קיסימפטה
novartis israel ltd - ofatumumab - תמיסה להזרקה - ofatumumab 50 mg/ml - ofatumumab